SCHEMBL24355437

SCHEMBL24355437

CC(=O)c1cc(C(F)(F)C(C)(C)O)ccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
DDR1 Q08345 1/20 0.36
AR P10275 2/20 0.34
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 3/20 0.33
FTO Q9C0B1 2/20 0.33
KDM6B O15054 1/20 0.33
TET3 O43151 1/20 0.33
KDM4A O75164 1/20 0.33
BBOX1 O75936 1/20 0.33
MAPT P10636 1/20 0.33
KDM5A P29375 1/20 0.33
KDM5C P41229 1/20 0.33
ASPH Q12797 1/20 0.33
KDM4D Q6B0I6 1/20 0.33
TET2 Q6N021 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.33
KDM7A Q6ZMT4 1/20 0.33
KDM8 Q8N371 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9444943 0.83 ALDH1A1 (0.46) ALDH1A1DDR1ARKDM4EFTO
SCHEMBL8563867 0.83 NOS3 (0.48) ALDH1A1DDR1GAAL3MBTL1KDM4E
SCHEMBL29553421 0.83 NOS3 (0.48) ALDH1A1DDR1GAAL3MBTL1KDM4E
SCHEMBL6170594 0.81 ALDH1A1 (0.47) ALDH1A1GAAKDM4EFTOKDM6B
SCHEMBL26069621 0.75 LMNA (0.38) ALDH1A1ARL3MBTL1NOS3NOS2
SCHEMBL24355441 0.75 NR3C1 (0.42) ARNOS3NOS2ADRB2LOXL2
SCHEMBL24355442 0.74 ALDH1A1 (0.39) ALDH1A1DDR1ARGAAL3MBTL1
SCHEMBL26068780 0.72 CYP1A2 (0.42) ALDH1A1GAAL3MBTL1KDM4ENOS3
SCHEMBL26068784 0.72 ADRB2 (0.44) ARNOS3NOS2ADRB2
SCHEMBL26069628 0.72 AR (0.30) DDR1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336606-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF SHANGHAI ZELGEN PHARMA.TECH CO., LTD. (CN) 2024-10-10 US disclosed
EP-4234548-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) 2023-08-30 EP disclosed
EP-4234548-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) 2023-08-30 EP disclosed
CN-116323590-A Substituted benzo or pyridopyrimidine amine inhibitor, preparation method and application thereof 苏州泽璟生物制药股份有限公司 2023-06-23 CN disclosed
WO-2022171018-A1 SUBSTITUTED BENZOPYRIMIDINE OR PYRIDOPYRIMIDINE AMINE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州泽璟生物制药股份有限公司 2022-08-18 WO disclosed
WO-2022083657-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 苏州泽璟生物制药股份有限公司 2022-04-28 WO disclosed
WO-2022083657-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF 苏州泽璟生物制药股份有限公司 2022-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240336606-A1 SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF WEE1, SOS1, WEE2 ALDH1A1 637/4885DDR1 2459/4885AR 4383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.